Pontex Polyblend Co. Ltd. AI Stock Analysis
Pontex Polyblend Co. Ltd. (8935) AI Stock Analysis
Pontex Polyblend Co. Ltd.
(TPEx:8935)
Pontex Polyblend scores poorly, driven primarily by a weak financial profile: four consecutive years of revenue decline, gross margin compression below 7%, and widening losses that are now eroding the equity base. A conservatively managed balance sheet (debt-to-equity of 0.59x, equity exceeding borrowings) and a return to positive operating and free cash flow in 2025 provide a partial cushion, but cash generation is minimal. Technicals reinforce the caution, with the stock trading below all major moving averages and negative MACD momentum. Valuation offers no offset given negative earnings and the absence of a dividend. Earnings call and corporate event data were unavailable and excluded, with their weight redistributed to the remaining components.
Pontex Polyblend Co. Ltd. (8935) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- TWD 1.95B
- Dividend Yield
- ―
- Average Volume (3M)
- 116.46K
- Price to Earnings (P/E)
- -28.7
- Beta (1Y)
- 0.92
- Revenue Growth
- -13.84%
- EPS Growth
- 12.29%
- Country
- TW
- Employees
- 215
- Sector
- General
- Sector Strength
- 55
- Industry
- Chemicals - Specialty
Pontex Polyblend Co. Ltd. Business Overview & Revenue Model
Company Description
Pontex Polyblend Co., Ltd., established in 1982 and headquartered in Taichung City, Taiwan, is a global enterprise specializing in two core areas: the production of engineering plastics compound materials and footwear manufacturing through injection...
Pontex Polyblend Co. Ltd. Financial Statement Overview
Summary
Fundamentals are weak and deteriorating. Revenue has fallen four straight years (from NT$1.38bn in 2021 to NT$518m in 2025, -62% cumulatively), gross margin has compressed to just 6.9%, and the company posted an operating loss of NT$86.9m and a net loss of NT$86.6m (-16.7% net margin), with EBITDA now sharply negative. The balance sheet is the relative bright spot: debt has been cut to NT$510m, equity of NT$866m exceeds borrowings, and debt-to-equity sits at a conservative 0.59x — though equity is eroding from accumulated losses and ROE is roughly -10%. Cash flow improved modestly, with operating cash flow swinging to +NT$25.7m and free cash flow to +NT$15.5m, but the absolute level is minimal (about 5% of revenue) and its sustainability is questionable while earnings remain deeply negative.
Income Statement
15Very NegativeBalance Sheet
50NeutralCash Flow
42Neutral| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 492.63M | 518.24M | 553.24M | 594.31M | 946.48M | 1.38B |
| Gross Profit | 58.60M | 35.63M | 58.56M | 67.56M | 172.44M | 210.31M |
| EBITDA | -23.78M | -46.88M | -11.92M | 136.00K | 96.77M | 111.82M |
| Net Income | -65.00M | -86.60M | -73.34M | -69.90M | 27.36M | 43.46M |
Balance Sheet | ||||||
| Total Assets | 1.44B | 1.45B | 1.50B | 1.55B | 1.72B | 1.77B |
| Cash, Cash Equivalents and Short-Term Investments | 282.48M | 253.65M | 192.59M | 190.43M | 217.45M | 143.46M |
| Total Debt | 516.62M | 510.16M | 464.83M | 587.88M | 787.88M | 857.96M |
| Total Liabilities | 575.68M | 587.94M | 537.23M | 679.78M | 883.17M | 984.07M |
| Stockholders Equity | 866.57M | 865.80M | 967.49M | 865.75M | 837.87M | 783.67M |
Cash Flow | ||||||
| Free Cash Flow | 44.65M | 15.47M | -32.29M | 58.58M | 135.02M | 20.41M |
| Operating Cash Flow | 55.40M | 25.68M | -4.01M | 79.51M | 146.99M | 39.30M |
| Investing Cash Flow | 4.99M | 8.62M | -21.91M | -39.01M | -46.82M | -18.08M |
| Financing Cash Flow | 62.77M | 45.13M | 31.00M | -77.78M | -75.89M | -4.56M |
Pontex Polyblend Co. Ltd. Peers Comparison
Overall Rating
TW:174256Neutral
TW:173553Neutral
TW:132351Neutral
TW:122044Neutral
TW:132541Neutral
TW:893539Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 56Neutral | TWD 1.99B | -40.88 | ― | ― | -39.62% | 56.82% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 53Neutral | TWD 1.90B | 16.50 | ― | 3.37% | 1.82% | 132.90% | |
| 51Neutral | TWD 1.99B | 17.09 | ― | 4.15% | -3.86% | -37.34% | |
| 44Neutral | TWD 1.79B | 154.70 | ― | 2.03% | -5.47% | -79.97% | |
| 41Neutral | TWD 2.16B | -42.66 | ― | 1.19% | -21.19% | 47.07% | |
| 39Underperform | TWD 1.96B | -28.69 | ― | ― | -13.84% | 12.29% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TW:8935 | Pontex Polyblend Co. Ltd. | 17.40 | -1.25 | -6.70% | |
| TW:1220 | Tai Roun Products Co.,Ltd. | 9.87 | -2.66 | -21.20% | |
| TW:1323 | Yonyu Plastics Co., Ltd | 21.70 | 2.99 | 15.98% | |
| TW:1325 | Universal Incorporation | 25.30 | -5.95 | -19.04% | |
| TW:1735 | Evermore Chemical Industry Co., Ltd. | 19.30 | 4.87 | 33.72% | |
| TW:1742 | Taiwan Wax Co., Ltd. | 21.20 | 7.50 | 54.74% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 09, 2026
